NCT00357812

Brief Summary

The aim of this study is to compare the safety, specificity, sensitivity and ease of procedure of two potential diagnostic assays for HSV-1 detection in the cornea. Through the use of this new diagnostic assay, correct and early intervention would not only reduce corneal scarring from HSK, but it would also allow the initiation of appropriate treatment for HSV mimicking keratitis. HSV-1 infection of the eye can result in corneal scarring and blindness. Early diagnosis of this condition and appropriate treatment is of utmost importance. Various ocular surface conditions can mimic herpetic keratitis in their clinical presentation and can result in diagnostic confusion. Inappropriate or delayed treatment of herpetic corneal disease results in increased morbidity. In the UK at present clinical presentation is the mainstay of diagnosis. Unfortunately these cases often present to the most inexperienced clinical staff resulting in variability in diagnostic acumen. This often results in a delay or inappropriate diagnosis of herpetic keratitis. Laboratory techniques presently available to aid diagnosis are infrequently used in clinical practice. There are various reasons for their lack of use. Historically viral culture techniques were the mainstay of investigation but were slow, requiring weeks to provide a result. PCR is now replacing culture techniques and is relatively quick, reliable and sensitive. Many clinicians within the UK are still not fully informed of these advances and are therefore not utilizing these techniques to supplement clinical diagnosis. We propose to investigate the use of topically applied fluorescent antibody against active replicating HSV-1 in a droplet form and real time PCR detection of the virus. If successful this should increase the potential diagnostic capabilities of GPs and other less experienced health care workers. Such tests should reduce variability in diagnosis and the dependency on experienced ophthalmologists to diagnose the condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2006

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 28, 2006

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2006

Completed
6.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

January 15, 2013

Status Verified

November 1, 2012

First QC Date

July 26, 2006

Last Update Submit

January 14, 2013

Conditions

Keywords

Herpes Simplex Virus Type 1Herpes Simplex KeratitisCorneaDendretic UlcerIn vivo Confocal MicroscopyNested Multi-plex PCRMonoclonal AntibodyGlycoprotein DGlycoprotein C

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over the age of 16 years in which the cause of keratitis is difficult to diagnose and in which HSK has to be excluded will be enrolled for this study

You may qualify if:

  • Patients over the age of 16 years in which the cause of keratitis is difficult to diagnose and in which HSK has to be excluded will be enrolled for this study

You may not qualify if:

  • Immunosuppressed patients including patients treated with systemic steroids will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Birmingham and Midlands Eye Clinic

Birmingham, Midlands, B18 79H, United Kingdom

Location

Bedford Hospital Ophthalmology Department and Acute Eye Clinic

Bedford, United Kingdom

Location

Royal Victoria Hospital

Belfast, United Kingdom

Location

MeSH Terms

Conditions

Keratitis, HerpeticCorneal Diseases

Condition Hierarchy (Ancestors)

Eye Infections, ViralEye InfectionsInfectionsHerpes SimplexHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesKeratitisEye Diseases

Study Officials

  • Tara Moore, PhD

    Department of Biomedical Sciences, University of Ulster

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 26, 2006

First Posted

July 28, 2006

Study Start

September 1, 2006

Study Completion

November 1, 2012

Last Updated

January 15, 2013

Record last verified: 2012-11

Locations